TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10086963

Group type: EXPERIMENTAL
Intervention: Implantable cardiac defibrillator (ICD)
Number of subjects: 900

Group type: COMPARATOR
Intervention: No antiarrhythmic therapy (Control)
Number of subjects: 900
Study: 7552790

Group type: EXPERIMENTAL
Intervention: Management and prevention of vascular catheter related infections
Number of subjects: 0
Study: 2688071

Group type: COMPARATOR
Intervention: trimethoprim‐sulfamethoxazole (TMP‐SMX)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: norfloxacin (NF)
Number of subjects: 343
Study: 5389

Group type: EXPERIMENTAL
Intervention: 1.0 mg fluoride - 42 mg sucrose tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride-free, sucrose-containing placebo tablets
Number of subjects: 0
Study: 31594690

Group type: EXPERIMENTAL
Intervention: GLPG2737 (75mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 30537153

Group type: EXPERIMENTAL
Intervention: Self-management programme plus usual care
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 135
Study: 28456108

Group type: EXPERIMENTAL
Intervention: PDQ‐11 (Personal Diabetes Questionnaire scale)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: PDQ‐11 subscales
Number of subjects: 411
Study: 23293007

Group type: EXPERIMENTAL
Intervention: PLAYgrounds programme (intervention group)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control group (light PA)
Number of subjects: 1500
Study: 22706585

Group type: EXPERIMENTAL
Intervention: Clopidogrel (CPG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rabeprazole (RBRZ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Co-administration of Clopidogrel and Rabeprazole
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ADP-induced platelet aggregation
Number of subjects: 20
Study: 21928866

Group type: EXPERIMENTAL
Intervention: Single-focus alcohol risk-reduction intervention
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Single-focus HIV risk-reduction intervention
Number of subjects: 154

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 154
Study: 19935143

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation with relaxation therapy (CPRT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Cardiac rehabilitation alone (CPA)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Cardiac-related hospital admissions
Number of subjects: 81
Study: 20970896

Group type: EXPERIMENTAL
Intervention: diet/probiotics
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: diet/placebo
Number of subjects: 256

Group type: COMPARATOR
Intervention: control/placebo
Number of subjects: 256
Study: 15763433

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (75 mg daily)
Number of subjects: 639
Study: 12215748

Group type: EXPERIMENTAL
Intervention: Low-dose sublingual isosorbide dinitrate (2.5 mg) during HUTT
Number of subjects: 43

Group type: COMPARATOR
Intervention: Isoproterenol infusion (1 to 3 µg/min) during HUTT
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Passive period of HUTT
Number of subjects: 43
Study: 9694469

Group type: EXPERIMENTAL
Intervention: Injection rate of 2 ml/sec
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Injection rate of 3 ml/sec
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Injection rate of 4 ml/sec
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Injection rate of 5 ml/sec
Number of subjects: 100
Study: 7521377

Group type: EXPERIMENTAL
Intervention: IgM anti‐HCV
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HCV RNA
Number of subjects: 40
Study: 2918332

Group type: EXPERIMENTAL
Intervention: Excisional biopsy plus radiation
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Breast conservation surgery
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (Mastectomy)
Number of subjects: 191
Study: 4940158

Group type: EXPERIMENTAL
Intervention: D. pteronyssinus extract
Number of subjects: 11

Group type: COMPARATOR
Intervention: Human skin scales extract
Number of subjects: 11
Study: 11452241

Group type: EXPERIMENTAL
Intervention: Dapsone (daily and weekly dosing)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapsone with rifabutin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapsone in black children
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapsone in children younger than 2 years old
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dapsone exposure parameters
Number of subjects: 60
Study: 30919036

Group type: EXPERIMENTAL
Intervention: 4 g myo-Inositol combined with 400 mg folic acid
Number of subjects: 50

Group type: COMPARATOR
Intervention: 400 mg folic acid
Number of subjects: 50
Study: 29546297

Group type: EXPERIMENTAL
Intervention: MUFA-rich meals
Number of subjects: 32

Group type: COMPARATOR
Intervention: SFA-rich meals
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: n-6 PUFA-rich meals
Number of subjects: 32
Study: 27098499

Group type: EXPERIMENTAL
Intervention: Oral sucrose (2 mL of 88% sucrose solution)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (2 mL of placebo solution)
Number of subjects: 87
Study: 24651746

Group type: EXPERIMENTAL
Intervention: Submillisievert IMR (iterative model reconstruction)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Submillisievert iDose
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard-dose FBP (filtered back projection)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Submillisievert IMR
Number of subjects: 10
Study: 21958117

Group type: EXPERIMENTAL
Intervention: Bronchial allergen challenge with HDM
Number of subjects: 27
Study: 20356641

Group type: EXPERIMENTAL
Intervention: Maternal employment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased family income and access to public health insurance coverage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal employment (secondary analysis)
Number of subjects: 0
Study: 17641250

Group type: EXPERIMENTAL
Intervention: Transdermal GTN 1.2 mg for 2 hours
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Pentaerythrityl tetranitrate (PETN) 80 mg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN) 40 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 37
Study: 15738296

Group type: EXPERIMENTAL
Intervention: Nitric oxide (NO) inhalation during acute vasodilator test
Number of subjects: 22
Study: 12376307

Group type: EXPERIMENTAL
Intervention: Five-center needling therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine acupuncture (control group)
Number of subjects: 78
Study: 9793091

Group type: EXPERIMENTAL
Intervention: Membrane 1400T (30 patients)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Membrane 1401T (24 patients)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (27 patients)
Number of subjects: 81
Study: 8577573

Group type: EXPERIMENTAL
Intervention: Irregular geometric shapes of horses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silhouettes of horse shapes and enantiomorphic deltoid shapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single oblique contours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertical orientation of deltoid shapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertically oriented horse silhouettes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing from two positions
Number of subjects: 0
Study: 2782131

Group type: EXPERIMENTAL
Intervention: MLAgCu250
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MLCu375
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiloads (MLs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nova-T
Number of subjects: 0
Study: 1218275

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (RT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 250

Group type: COMPARATOR
Intervention: Surgery + postoperative RT
Number of subjects: 250
Study: 30507875

Group type: EXPERIMENTAL
Intervention: Acetaminophen (200 mg/kg/d)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acemetacin (5 mg/kg/d)
Number of subjects: 14
Study: 28374207

Group type: EXPERIMENTAL
Intervention: Mindfulness group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Support and information group
Number of subjects: 0
Study: 25415807

Group type: EXPERIMENTAL
Intervention: ZS‐9 (2.5 g)
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: ZS‐9 (5 g)
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: ZS‐9 (10 g)
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: ZS‐9 (5 g) during maintenance phase
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: ZS‐9 (10 g) during maintenance phase
Number of subjects: 753

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 753

Group type: COMPARATOR
Intervention: Placebo during maintenance phase
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Adverse events (ZS‐9)
Number of subjects: 753

Group type: COMPARATOR
Intervention: Adverse events (Placebo)
Number of subjects: 753
Study: 22639824

Group type: EXPERIMENTAL
Intervention: Palatally displaced canines (PDC)
Number of subjects: 1674

Group type: EXPERIMENTAL
Intervention: Buccally displaced canines (BDC)
Number of subjects: 1674

Group type: COMPARATOR
Intervention: Control group (no maxillary canine impaction)
Number of subjects: 1674
Study: 21146765

Group type: EXPERIMENTAL
Intervention: Escape from Diab and Nanoswarm: Invasion from Inner Space video games
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group played diet and physical activity knowledge‐based games
Number of subjects: 133
Study: 18718819

Group type: EXPERIMENTAL
Intervention: Creon for children (CfC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Creon 10000 (C10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 16825682

Group type: EXPERIMENTAL
Intervention: Bland meal after a bland diet (BAB)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chili meal after a bland diet (CAB)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chili meal after a chili-containing diet (CAC)
Number of subjects: 36
Study: 14707470

Group type: EXPERIMENTAL
Intervention: Suckling
Number of subjects: 0
Study: 10618526

Group type: EXPERIMENTAL
Intervention: Accelerated schedule of recombinant Hepatitis B vaccine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional schedule of recombinant Hepatitis B vaccine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Booster dose for children with anti‐HBsAg concentrations below 10 mUI/ml
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Recombinant HBV vaccine administered earlier
Number of subjects: 200
Study: 8859286

Group type: EXPERIMENTAL
Intervention: 10 units of Botulinum A exotoxin (BTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 0
Study: 1517641

Group type: EXPERIMENTAL
Intervention: Hopkins Pain Rating Instrument (HPRI)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Verbal Descriptor Scale (VDS)
Number of subjects: 71
Study: 6394890

Group type: EXPERIMENTAL
Intervention: 5 ng prostacyclin (PGI2)/kg/min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 12
Study: 31145188

Group type: EXPERIMENTAL
Intervention: Wide area circumferential ablation (WACA)
Number of subjects: 260
Study: 29880769

Group type: EXPERIMENTAL
Intervention: BLISS (Baby‐Led Introduction to SolidS)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control
Number of subjects: 206
Study: 26001339

Group type: EXPERIMENTAL
Intervention: Ciclesonide 80 μg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 μg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ciclesonide 80 μg and 160 μg
Number of subjects: 60
Study: 25034652

Group type: EXPERIMENTAL
Intervention: Multidisciplinary pain therapy for 4 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Patients with FM
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Insecurely attached FM patients
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Securely attached FM patients
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cytokine levels
Number of subjects: 43
Study: 22898059

Group type: EXPERIMENTAL
Intervention: 10 Top Tips (10TT) intervention
Number of subjects: 520

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 520
Study: 20716270

Group type: EXPERIMENTAL
Intervention: En bloc closure of the peritoneum and fascia with Premilene suture (Group A)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: En bloc closure of the peritoneum and fascia with Polydioxanone suture (Group B)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Separate closure of the peritoneum and fascia with single stitches of Ethibond suture (Group C)
Number of subjects: 191
Study: 17640311

Group type: EXPERIMENTAL
Intervention: Fractionated Plasma Separation and Adsorption (FPSA)
Number of subjects: 0
Study: 16336072

Group type: EXPERIMENTAL
Intervention: More frequent self-weighing in weight loss trial
Number of subjects: 3026

Group type: EXPERIMENTAL
Intervention: More frequent self-weighing in weight gain prevention trial
Number of subjects: 3026

Group type: COMPARATOR
Intervention: Control group in weight gain prevention trial
Number of subjects: 3026

Group type: EXPERIMENTAL
Intervention: Intervention group in weight gain prevention trial
Number of subjects: 3026

Group type: COMPARATOR
Intervention: Control group in weight loss trial
Number of subjects: 3026

Group type: EXPERIMENTAL
Intervention: Intervention group in weight loss trial
Number of subjects: 3026
Study: 12409326

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,250 mg/m(2) days 1 and 8 plus cisplatin 75 mg/m(2) day 2 every 21 days (GC arm)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Paclitaxel 225 mg/m(2) (3‐hour infusion) then carboplatin (AUC 6 mg/mL x min) on day 1 every 21 days (PCb arm)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Vinorelbine 25 mg/m(2)/wk for 12 weeks then every other week plus cisplatin 100 mg/m(2) day 1 every 28 days (VC arm)
Number of subjects: 612
Study: 10334422

Group type: EXPERIMENTAL
Intervention: Oral coenzyme Q for 3 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 30
Study: 7493170

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2020274

Group type: EXPERIMENTAL
Intervention: 8% glucose/electrolyte drink (G)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Flavored water placebo (P)
Number of subjects: 7
Study: 6176791

Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 40
Study: 30159300

Group type: EXPERIMENTAL
Intervention: Eccentric training (ET) - 12-week downhill walking exercise on treadmill
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group - COPD conventional medications and walking on paved surfaces
Number of subjects: 32
Study: 27912935

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Granule (BHG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 25707709

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (calibrated to achieve blood concentrations of 20, 80 and 120 mg/dL)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 18
Study: 23505170

Group type: EXPERIMENTAL
Intervention: Curves program (30-min exercise circuit and high-vegetable/low-fat/calorie-restricted diet) for 6 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist control arm (6 months of observation)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Curves program (30-min exercise circuit and high-vegetable/low-fat/calorie-restricted diet) for 6 months followed by observation
Number of subjects: 42
Study: 20143247

Group type: EXPERIMENTAL
Intervention: Inhalation of pure oxygen
Number of subjects: 18

Group type: COMPARATOR
Intervention: Inhalation of air (placebo)
Number of subjects: 18
Study: 17936285

Group type: EXPERIMENTAL
Intervention: GnRH antagonist administration
Number of subjects: 1069

Group type: EXPERIMENTAL
Intervention: GnRH antagonist administration (early studies)
Number of subjects: 1069

Group type: EXPERIMENTAL
Intervention: GnRH antagonist administration (later studies)
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1069
Study: 16842977

Group type: EXPERIMENTAL
Intervention: Diabetes Awareness and Rehabilitation Training (DART)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual Care plus Information (UCI)
Number of subjects: 64
Study: 14998561

Group type: EXPERIMENTAL
Intervention: Omeprazole 20mg b.i.d. with clarithromycin 500 mg b.i.d.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg b.i.d. with clarithromycin 500 mg b.i.d.
Number of subjects: 8
Study: 10882612

Group type: EXPERIMENTAL
Intervention: Transgenic potato (n=20)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Wild-type potato (n=4)
Number of subjects: 24
Study: 9366865

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg daily)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 580
Study: 1589080

Group type: EXPERIMENTAL
Intervention: Ranitidine (50 mg intravenously 30‐60 minutes before the operation)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ranitidine in association with metoclopramide
Number of subjects: 75
Study: 2986823

Group type: EXPERIMENTAL
Intervention: Levamisole combined with postoperative radiotherapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Levamisole in postmenopausal patients
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Levamisole treatment
Number of subjects: 72
Study: 3298080

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 31729280

Group type: EXPERIMENTAL
Intervention: Victim sexual orientation (bisexual, lesbian, heterosexual)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Victim sexual orientation (bisexual)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Perception of victim as more promiscuous
Number of subjects: 826
Study: 30499511

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of ranibizumab, 0.05 ml, administered twice with one-month interval.
Number of subjects: 45
Study: 27760796

Group type: EXPERIMENTAL
Intervention: Duration of resuscitation (up to 37.0 minutes)
Number of subjects: 11368

Group type: EXPERIMENTAL
Intervention: Duration of resuscitation (30-40 minutes)
Number of subjects: 11368

Group type: EXPERIMENTAL
Intervention: Resuscitation duration
Number of subjects: 11368

Group type: EXPERIMENTAL
Intervention: Resuscitation duration (up to 47 minutes)
Number of subjects: 11368
Study: 25552210

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block with 0.25% bupivacaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Local wound infiltration with 0.25% bupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 45
Study: 21820233

Group type: EXPERIMENTAL
Intervention: Postoperative administration of oral pregabalin 75 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Preoperative administration of oral pregabalin 75 mg
Number of subjects: 40
Study: 20151772

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (home televisits with a dietitian or nurse educator every 4-6 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (non-intervention subjects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 0
Study: 18093573

Group type: EXPERIMENTAL
Intervention: Pictures of fear-relevant animals (snakes and spiders)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Fear-relevant distracter (snake for snake fearful children)
Number of subjects: 81
Study: 16999232

Group type: EXPERIMENTAL
Intervention: Gene therapy (specific viral-based therapies not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 14609895

Group type: EXPERIMENTAL
Intervention: 30% sucrose intraoral administration
Number of subjects: 11
Study: 10674411

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 148

Group type: COMPARATOR
Intervention: No drugs (Control)
Number of subjects: 148
Study: 9172968

Group type: EXPERIMENTAL
Intervention: Maprotiline (75 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fluvoxamine (100 mg/day)
Number of subjects: 40
Study: 8279199

Group type: EXPERIMENTAL
Intervention: Employed men
Number of subjects: 2106

Group type: EXPERIMENTAL
Intervention: Employed women
Number of subjects: 2106

Group type: COMPARATOR
Intervention: Non-employed men and women
Number of subjects: 2106
Study: 2879617

Group type: EXPERIMENTAL
Intervention: Reperfusion strategy
Number of subjects: 533

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Early supportive therapy with beta-blockade and calcium antagonists
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Symptom limited bicycle stress test, radionuclide ventriculography, and 24 hour ambulatory electrocardiogram
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: History of previous myocardial infarction or heart failure during the current episode
Number of subjects: 533
Study: 31096121

Group type: EXPERIMENTAL
Intervention: Ultrasound examination
Number of subjects: 42
Study: 29595562

Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg/d)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (1 g/d of lactose powder)
Number of subjects: 88
Study: 26194270

Group type: EXPERIMENTAL
Intervention: Training program (meditation, breathing exercises, cold exposure)
Number of subjects: 0
Study: 24076283

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg on admission, followed by 20 mg/day)
Number of subjects: 504

Group type: COMPARATOR
Intervention: No statin treatment (control group)
Number of subjects: 504
Study: 23107222

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 20413437

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients
Number of subjects: 25
Study: 18625676

Group type: EXPERIMENTAL
Intervention: Sitaxsentan at 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bosentan
Number of subjects: 0